Author information:
(1)Department of Biological Regulation, Weizmann Institute of Science, Rehovot, 
Israel.
(2)Department of Cancer Genetics, Institute for Cancer Research, Oslo University 
Hospital, The Norwegian Radium Hospital, Oslo, Norway K.G. Jebsen Centre for 
Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, 
Oslo, Norway.
(3)Department of Computer Sciences, Technion-Israel Institute of Technology, 
Haifa, Israel.
(4)Division of Molecular Genome Analysis, German Cancer Research Center, 
Heidelberg, Germany.
(5)Division of RNA Biology & Cancer (B150), German Cancer Research Center 
(DKFZ), Heidelberg, Germany Institute of Pathology, University Hospital 
Heidelberg, Heidelberg, Germany.
(6)Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, 
Israel.
(7)Department of Oncology, Luxembourg Institute of Health, Luxembourg City, 
Luxembourg.
(8)Division of RNA Biology & Cancer (B150), German Cancer Research Center 
(DKFZ), Heidelberg, Germany Institute of Pathology, University Hospital 
Heidelberg, Heidelberg, Germany German Cancer Consortium (DKTK), Freiburg, 
Germany Division of Cancer Research, Department of Thoracic Surgery, Faculty of 
Medicine, Medical Center - University of Freiburg, University of Freiburg, 
Freiburg, Germany‡
(9)Department of Computer Sciences, Technion-Israel Institute of Technology, 
Haifa, Israel Agilent Laboratories, Petach-Tikva, Israel.
(10)Department of Biological Regulation, Weizmann Institute of Science, Rehovot, 
Israel yosef.yarden@weizmann.ac.il.